Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bekasi Asri Pemula Tbk (BAPA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Bekasi Asri Pemula TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bekasi Asri Pemula Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bekasi Asri Pemula Tbk trades at Rp240 (market cap 186.62B, 71.44M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.1× Bekasi Asri Pemula Tbk's market cap, and Bekasi Asri Pemula Tbk is more actively traded (71.44M versus 1.44M). Which is the better fit depends on your goals.

BAPALABS
Market Cap
186.62B584.6B
Volume
71.44M1.44M
Lot
714.38K14.4K
Turnover
18.3B209.72M
Average Price
256.12145.64
Value
18.3B209.72M
Indicative Equilibrium Price
240146
Indicative Equilibrium Volume
16.81K753

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BAPA
View details
LABS
View details

About Bekasi Asri Pemula Tbk

PT Bekasi Asri Pemula Tbk (the company) was established on 22 Oct 1993 based on Notaries Deed No. 909 and the deed of establishment was approved by the the Ministry of Justice dated Mar 11, 1994. The Company's articles of association has been amended several times, most recently by notarial deed No. 30 of Wijanto Suwongso, S.H., dated Feb 28, 2007, concerning among others, increase authorized, Paid up Capital and public offering.

Read more on BAPA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS